Vanderbilt researchers on guanfacine for hyperadrenergic patients, Pamela Roff, B.S. posted on the topic

Description

Vanderbilt researchers recently presented new data on the use of guanfacine in 47 hyperadrenergic #POTS patients. They note that 72% of patients responded well…

Pamela Roff, B.S. - Provider Relations - South Denver Cardiology Associates

Silvia De Rosa on LinkedIn: Acute Kidney Injury (AKI) and Blood Purification Therapy Survey

Brian Robert Tees, MBA on LinkedIn: Transplant Genomics is taking the mission to Capitol Hill! This week, key…

Pamela Roff, B.S. on LinkedIn: I'm excited to announce that I've accepted a new position as Provider…

Pamela Roff, B.S. - Provider Relations - South Denver Cardiology Associates

Rishad Usmani, MD on LinkedIn: There is tension between personalized care and evidence based care…

Silvia De Rosa on LinkedIn: Acute Kidney Injury (AKI) and Blood Purification Therapy Survey

Pamela Roff, B.S. on LinkedIn: What is POTS?

Vanderbilt researchers on guanfacine for hyperadrenergic patients, Pamela Roff, B.S. posted on the topic

Pamela Roff, B.S. on LinkedIn: Research News: Researchers in Germany recently described a group of…

Why Physicians Commit Suicide - Pamela Wible MD

Pamela Roff, B.S. on LinkedIn: CALLING ALL RESEARCHERS! Dysautonomia International is now accepting grant…

Brian Robert Tees, MBA on LinkedIn: Transplant Genomics is taking the mission to Capitol Hill! This week, key…

Related products

Update of Individualized Treatment Strategies for Postural Orthostatic Tachycardia Syndrome in Children. - Abstract - Europe PMC

Cracking the Code of Dysautonomia: POTS, Orthostatic Hypotension, and Heart Health

Postural Orthostatic Tachycardia Syndrome A Dermatologic Perspective and Successful Treatment with Losartan, JCAD

Dysautonomia Intl. on X: New research from Mayo Clinic finds that the different “phenotypes” of #POTS (hyperadrenergic, hypovolemic, neuropathic) can't be distinguished based on symptoms, and that many patients experience more than